Drug pricing, patent losses and deals: Here's what pharma execs see ahead in the industry - CNBC
Big pharma is grappling with new drug pricing deals and roughly $300 billion in potential lost revenue from patent expirations of blockbuster drugs.
Search Group
Share To
Comments
About Screade
Screade® Inc. version 5f3dbda, copyright 2016 - 2026
Blocked Users
Customize Dark Theme
Forgot your password?
Forgot your password?
Invite your friends
Please type emails of people you want to invite, we will send them invitation email on your behalf. Separate emails with comma if you want to invite multiple friends.
Comments